Carl June (Brian Ach/Getty Images for TIME 100 Health Summit)

Carl June lends 'wings' to Chi­nese CAR-T start­up led by for­mer post­doc, pur­su­ing off-the-shelf ap­proach with CRISPR fla­vor

Carl June still has plen­ty of en­er­gy to bring forth new it­er­a­tions of CAR-T tech­nol­o­gy — wher­ev­er they’re com­ing from.

Adding an­oth­er role to his al­ready lengthy list of ti­tles, June is join­ing the sci­en­tif­ic ad­vi­so­ry board at Nan­jing Bio­heng Biotech, where he will serve as chair­man.

The ap­point­ment, if slight­ly out of the or­di­nary, is both a tes­ta­ment to the fruit­ful­ness of June’s lab at the Uni­ver­si­ty of Penn­syl­va­nia and Chi­na’s in­creas­ing ap­peal to biotech en­tre­pre­neurs ed­u­cat­ed over­seas.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.